Cerebrovascular contractility after clot removal in monkey subarachnoid haemorrhage

Clinical and Experimental Pharmacology and Physiology

Volumn 26, Issue 5-6, 1999, Pages 485-488

  Tsuji, Tsutomu ^a   Cook, David A ^c   Weir, Bryce K A ^d   Handa, Yuji ^b   Chiba, Shigetoshi ^a   Kobayashi, Shigeaki ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

5 hydroxytryptamine; Basilar arteries; Clot removal; Contraction; Early surgery; Middle cerebral arteries; Monkey; Noradrenaline; Potassium chloride; Subarachnoid haemorrhage

Indexed keywords

NORADRENALIN; POTASSIUM CHLORIDE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CONSTRICTION; ARTICLE; BASILAR ARTERY; BLOOD CLOT RETRACTION; BRAIN VASOSPASM; DRUG EFFECT; DRUG POTENCY; DRUG RESPONSE; MACACA; MIDDLE CEREBRAL ARTERY; NONHUMAN; SUBARACHNOID HEMORRHAGE;

ANIMALS; BASILAR ARTERY; BRAIN; CEREBRAL ARTERIES; CEREBROVASCULAR CIRCULATION; MACACA FASCICULARIS; NOREPINEPHRINE; POTASSIUM CHLORIDE; SEROTONIN; SUBARACHNOID HEMORRHAGE; VASOCONSTRICTION;

EID: 0032982232     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.1999.03063.x     Document Type: Article

References (15)

1. 1. Osaka K. Prolonged vasospasm produced by the breakdown products of erythrocytes. J. Neurosurg. 1977; 47: 403-11.
2. 2. Macdonald RL, Weir BKA. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 1991; 22: 971-82.
3. 3. Haley Jr EC, Kassell NF, Torner JC. The International Cooperative Study on the Timing of Aneurysm Surgery. The North American Experience. Stroke 1992; 23: 205-14.
4. 4. Nosko M, Weir BKA, Lunt A, Grace M, Allen P, Mielke B. Effect of clot removal at 24 hours on chronic vasospasm after SAH in the primate model. J. Neurosurg. 1987; 66: 416-22.
5. 5. Findlay JM, Macdonald RL, Weir BKA, Grace MGA. Surgical manipulation of primate cerebral arteries in established vasospasm. J. Neurosurg. 1991; 75: 425-32.
6. 6. Handa Y, Weir BKA, Nosko M, Mosewich R, Tsuji T, Grace M. The effect of timing of clot removal on chronic vasospasm in a primate model. J. Neurosurg. 1987; 67: 558-64.
7. 7. Chiba S, Tsuji T. Vascular responsiveness of isolated, perfused basilar arteries in dogs and monkeys. Tohoku J. Exp. Med. 1985; 146: 363-70.
8. 8. Chang J-Y, Hardebo JE, Owman C, Sahlin C, Svendgaard N-A. Nerves containing serotonin, its interaction with noradrenaline, and characterization of serotonin receptors in cerebral arteries of monkey. J. Autonom. Pharmacol. 1987; 7: 317-29.
9. 9. Hirst GDS, Neild TO, Silverberg GD. Noradrenaline receptors on the rat basilar artery. J. Physiol. 1982; 328: 351-60.
10. 10. Toda N, Ozaki T, Ohta T. Cerebrovascular sensitivity to vasoconstricting agents induced by subarachnoid hemorrhage and vasospasm in dogs. J. Neurosurg. 1977; 46: 296-303.
11. 11. Krueger C, Weir B, Nosko M, Cook D, Norris S. Nimodipine and chronic vasospasm in monkeys: Part 2. Pharmacological studies of vessels in spasm. Neurosurgery 1985; 16: 137-40.
12. 12. Onoue H, Kaito N, Akiyama M, Tomii M, Tokudome S, Abe T. Altered reactivity of human cerebral arteries after subarachnoid hemorrhage. J. Neurosurg. 1995; 83: 510-15.
13. 13. Svendgaard N-A, Edvinsson L, Owman C, Sahlin C. Increased sensitivity of the basilar artery to norepinephrine and 5-hydroxytryptamine following experimental subarachnoid hemorrhage. Surg. Neurol. 1977; 8: 191-5.
14. 14. Sahlin C, Owman C, Chang J-Y, Delgado T, Salford LG, Svendgaard N-A. Changes in contractile response and effect of a calcium antagonist, nimodipine, in isolated intracranial arteries of baboon following experimental subarachnoid hemorrhage. Brain Res. Bull. 1990; 24: 355-61.
15. 15. Bevan JA, Bevan RD. Arterial wall changes in chronic cerebrovasospasm: In vitro and in vivo pharmacological evidence. Annu. Rev. Pharmacol. Toxicol. 1988; 28: 311-29.